MedPath

Clinical study comparing diagnostic rates between 24-hour Holter monitoring and portable ECG devices in Cardiogenic vertigo

Not Applicable
Completed
Conditions
Diseases of the circulatory system
Registration Number
KCT0009088
Lead Sponsor
Pusan National University Hospital
Brief Summary

During the 72-hour monitoring period, there was no significant difference in the overall detection rate of arrhythmia events between the wearable patch and conventional Holter monitoring (21.3% vs.17.0%, P > .001). Most patients (46/47) favored a wearable patch over Holter monitoring. The detection of CV was associated with a lower frequency of vertigo. The effectiveness of wearable ECG patch monitoring was comparable to conventional Holter monitoring in detecting CV. With its extended monitoring capability and patient preference, wearable patch monitoring holds promise as an alternative method for CV diagnosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
49
Inclusion Criteria

1. Patients with heart disease over 19 years of age
2. Recurrent dizziness lasting less than 5 minutes
3. Cases not explained by other neurological or neurotological diagnoses

Exclusion Criteria

1. Patients whose dizziness is determined to be caused by another vestibular disease such as vestibular neuritis or Meniere's disease
2. Patients whose dizziness was found to be caused by an organic central disease.
3. Patients who, in the judgment of the researcher, have clinically serious diseases (liver disease, kidney disease, malignant tumor, etc.) that make it difficult to participate in the study.
4. Other patients who find it difficult to participate according to the researcher's judgment.
5. Those who do not agree to participate in the study.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the diagnosis rate of cardiogenic dizziness after implementing 24-hour Holter monitoring and portable electrocardiogram device.
Secondary Outcome Measures
NameTimeMethod
Evaluate various factors that influence the diagnosis of cardiac vertigo(Dizziness duration, dizziness frequency, age, cause of heart disease, syncope time, etc.)
© Copyright 2025. All Rights Reserved by MedPath